Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 20 stocks, with a combined market cap of $3.05 trillion, total revenue of $724.29 billion and a weighted average PE ratio of 21.42.

Market Cap
3.05T
Revenue
724.29B
Profits
142.56B
PE Ratio
21.42
Profit Margin
19.68%
Dividend Yield
2.18%

20 Stocks

No. Symbol Company Name Market Cap % Change Volume Revenue
1LLYEli Lilly and Company592.95B3.29%6,310,03453.26B
2JNJJohnson & Johnson420.06B0.95%5,878,04690.63B
3ABBVAbbVie Inc.355.91B1.42%3,558,42258.33B
4AZNAstraZeneca PLC240.81B3.45%5,008,71956.50B
5NVSNovartis AG234.72B1.58%1,088,33155.19B
6NVONovo Nordisk A/S227.37B2.25%19,443,19749.11B
7MRKMerck & Co., Inc.206.59B3.00%11,050,34863.62B
8AMGNAmgen Inc.155.76B1.53%1,733,31434.92B
9GILDGilead Sciences, Inc.149.07B0.10%4,928,46128.86B
10PFEPfizer Inc.143.05B2.07%40,174,89663.83B
11SNYSanofi118.83B1.44%1,685,79553.71B
12BMYBristol-Myers Squibb Company97.40B2.79%10,114,23947.70B
13GSKGSK plc78.50B2.38%3,493,23943.34B
14BIIBBiogen Inc.19.82B4.86%1,549,19610.00B
15GRFSGrifols, S.A.9.09B0.38%1,159,7808.74B
16OGNOrganon & Co.2.43B3.43%3,709,9466.28B
17AMRNAmarin Corporation plc308.17M-59,739219.36M
18SCLXScilex Holding Company115.36M18.85%444,45350.71M
19MDCXMedicus Pharma Ltd.37.41M-6.25%226,063-
20MIRAMIRA Pharmaceuticals, Inc.27.52M1.36%209,890-